BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10584773)

  • 1. Recommended haloperidol and risperidone doses in first-episode psychosis.
    McGorry PD
    J Clin Psychiatry; 1999 Nov; 60(11):794-5. PubMed ID: 10584773
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
    Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone: once-daily dosage.
    Gupta S; Droney T
    Ann Clin Psychiatry; 1996 Dec; 8(4):221. PubMed ID: 8986319
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis.
    Pérez-Iglesias R; Mata I; Martínez-García O; Garcia-Unzueta MT; Amado JA; Valdizán EM; Vázquez-Barquero JL; Crespo-Facorro B
    J Clin Psychopharmacol; 2012 Dec; 32(6):804-8. PubMed ID: 23131886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal haloperidol dosage in first-episode psychosis.
    Zhang-Wong J; Zipursky RB; Beiser M; Bean G
    Can J Psychiatry; 1999 Mar; 44(2):164-7. PubMed ID: 10097837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic dosing strategies in acute schizophrenia.
    Janicak PG; Davis JM
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():35-40. PubMed ID: 8803658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of antipsychotic drugs.
    Osser DN; Akhter A
    Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW; Simpson GM
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
    Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A report of successful treatment of psychosis in epilepsy with risperidone.
    Mahgoub NA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):347-8. PubMed ID: 17827431
    [No Abstract]   [Full Text] [Related]  

  • 17. Determining the optimal dose of haloperidol in first-episode psychosis.
    Oosthuizen P; Emsley RA; Turner J; Keyter N
    J Psychopharmacol; 2001 Dec; 15(4):251-5. PubMed ID: 11769818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
    Lim HK; Kim JJ; Pae CU; Lee CU; Lee C; Paik IH
    Neuropsychobiology; 2010; 62(2):81-6. PubMed ID: 20523078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotic medications in the psychiatric emergency service.
    Currier GW
    J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence of a dose-response threshold for haloperidol in psychosis.
    Stone CK; Garve DL; Griffith J; Hirschowitz J; Bennett J
    Am J Psychiatry; 1995 Aug; 152(8):1210-2. PubMed ID: 7625474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.